• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌合并间质性肺疾病患者行手术治疗安全吗?

Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?

机构信息

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.

出版信息

Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620971137. doi: 10.1177/1753466620971137.

DOI:10.1177/1753466620971137
PMID:33167797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7659025/
Abstract

AIMS

Interstitial lung disease (ILD) is associated with the incidence of non-small cell lung cancer (NSCLC). Patients with ILD are at risk of acute exacerbation (AE) after pulmonary resection. However, there have been no recognized treatment guidelines for NSCLC patients with ILD on computed tomography (CT).

METHODS

We reviewed the medical records of 156 consecutive patients with ILD on high-resolution CT who have undergone pulmonary resection and between 2014 and 2018. Data regarding general information, imaging features, perioperative indicators, and long-term prognosis of patients were compared.

RESULTS

The mean patient age was 67.24 ± 6.80 years. Postoperative AE occurred in seven (4.5%) patients; five (71.4%) of the seven patients who had an AE died within 30 days. The incidence of postoperative AE was 5.3% among patients who underwent lobectomy ( = 6). Overall survivals (OS) was significantly poorer in patients with possible usual interstitial pneumonia (UIP)/UIP [hazard ratio (HR) 2.34, 95% confidence interval (CI) 1.11-4.95,  = 0.026] and severe postoperative complications (Grade ⩾3) ( no complication: HR 2.58, 95% CI 1.11-6.02,  = 0.028; mild complications: HR 6.05, 95% CI 2.69-13.6,  < 0.001). Age (HR 1.071, 95% CI 1.006-1.137,  = 0.030) and ILD patterns (HR 2.420, 95% CI 1.024-5.716,  = 0.044) were independent prognostic factors for OS. Forced vital capacity (FVC) (odds ratio 0.351, 95% CI 0.145-0.850,  = 0.020) was an independent prognostic factor for patients who needed postoperative intensive care unit intervention.

CONCLUSION

Pulmonary resection for NSCLC Patients with ILD on CT is a safe procedure. However, surgical indications for lobectomy need to be more carefully for these patients, especially for possible UIP/UIP patients and patients with lower FVC.

摘要

目的

间质性肺疾病(ILD)与非小细胞肺癌(NSCLC)的发病率有关。接受肺切除术的患者有发生急性加重(AE)的风险。然而,对于 CT 上有 ILD 的 NSCLC 患者,尚无公认的治疗指南。

方法

我们回顾了 2014 年至 2018 年间在高分辨率 CT 上接受肺切除术的 156 例 ILD 连续患者的病历。比较了患者的一般信息、影像学特征、围手术期指标和长期预后数据。

结果

患者平均年龄为 67.24±6.80 岁。7 例(4.5%)患者术后发生 AE,其中 5 例(71.4%)AE 患者在 30 天内死亡。行肺叶切除术的患者中术后 AE 的发生率为 5.3%(n=6)。可能为普通间质性肺炎(UIP)/UIP 的患者的总体生存率(OS)明显较差[风险比(HR)2.34,95%置信区间(CI)1.11-4.95,p=0.026]和严重术后并发症(等级≥3)(无并发症:HR 2.58,95%CI 1.11-6.02,p=0.028;轻度并发症:HR 6.05,95%CI 2.69-13.6,p<0.001)。年龄(HR 1.071,95%CI 1.006-1.137,p=0.030)和ILD 模式(HR 2.420,95%CI 1.024-5.716,p=0.044)是 OS 的独立预后因素。用力肺活量(FVC)(比值比 0.351,95%CI 0.145-0.850,p=0.020)是需要术后重症监护干预的患者的独立预后因素。

结论

CT 上有 ILD 的 NSCLC 患者接受肺切除术是安全的。然而,对于这些患者,肺叶切除术的手术适应证需要更加谨慎,特别是对于可能的 UIP/UIP 患者和 FVC 较低的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/4ae434abc602/10.1177_1753466620971137-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/cb974838d694/10.1177_1753466620971137-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/7694f692a93d/10.1177_1753466620971137-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/a013a94c8a49/10.1177_1753466620971137-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/4ae434abc602/10.1177_1753466620971137-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/cb974838d694/10.1177_1753466620971137-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/7694f692a93d/10.1177_1753466620971137-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/a013a94c8a49/10.1177_1753466620971137-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a03/7659025/4ae434abc602/10.1177_1753466620971137-fig4.jpg

相似文献

1
Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?肺癌合并间质性肺疾病患者行手术治疗安全吗?
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620971137. doi: 10.1177/1753466620971137.
2
Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.肺叶切除术与亚肺叶切除术治疗特发性肺纤维化合并临床Ⅰ期非小细胞肺癌的结果。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1089-1096.e1. doi: 10.1016/j.jtcvs.2017.03.116. Epub 2017 Apr 4.
3
Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.低用力肺活量可预测肺癌患者中与细胞毒性化疗相关的间质性肺疾病急性加重。
Lung Cancer. 2016 Jun;96:63-7. doi: 10.1016/j.lungcan.2016.03.017. Epub 2016 Mar 30.
4
Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.肺癌肺切除术后间质性肺疾病急性加重的影响因素及预测因素。
J Thorac Cardiovasc Surg. 2014 May;147(5):1604-1611.e3. doi: 10.1016/j.jtcvs.2013.09.050. Epub 2013 Nov 20.
5
Impact of interstitial lung disease on short-term and long-term survival of patients undergoing surgery for non-small-cell lung cancer: analysis of risk factors.间质性肺疾病对非小细胞肺癌患者手术短期和长期生存的影响:危险因素分析。
Eur J Cardiothorac Surg. 2013 Jan;43(1):e17-23. doi: 10.1093/ejcts/ezs560. Epub 2012 Nov 4.
6
Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery.胶原血管病相关间质性肺疾病对肺癌手术结局的影响。
Surg Today. 2017 Sep;47(9):1072-1079. doi: 10.1007/s00595-017-1476-z. Epub 2017 Feb 28.
7
The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.间质肺疾病-性别-年龄-生理学指数可预测合并肺癌行手术切除的间质肺疾病患者的预后。
Respiration. 2020;99(1):9-18. doi: 10.1159/000502849. Epub 2019 Sep 25.
8
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
9
Predictors for acute exacerbation of interstitial pneumonia following lung cancer surgery: a multicenter study.肺癌手术后间质性肺炎急性加重的预测因素:一项多中心研究。
BMC Pulm Med. 2024 Aug 1;24(1):377. doi: 10.1186/s12890-024-03177-5.
10
Preoperative CT Findings for Predicting Acute Exacerbation of Interstitial Pneumonia After Lung Cancer Surgery: A Multicenter Case-Control Study.术前 CT 对预测肺癌术后间质性肺炎急性加重的作用:一项多中心病例对照研究。
AJR Am J Roentgenol. 2021 Oct;217(4):859-869. doi: 10.2214/AJR.21.25499. Epub 2021 Apr 14.

引用本文的文献

1
Concomitant Idiopathic Pulmonary Fibrosis and Lung Cancer: An Updated Narrative Review.特发性肺纤维化与肺癌并存:最新叙述性综述
Adv Respir Med. 2025 Aug 18;93(4):31. doi: 10.3390/arm93040031.
2
Lung cancer resection in patients with underlying usual interstitial pneumonia: a meta-analysis.特发性间质性肺炎患者的肺癌切除术:一项荟萃分析。
BMJ Open Respir Res. 2023 Mar;10(1). doi: 10.1136/bmjresp-2022-001529.
3
Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development.从肺纤维化到肺癌发展的分子机制和细胞贡献。

本文引用的文献

1
Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.以 30 天死亡率作为非小细胞肺癌特定部位的质量指标具有挑战性。
J Thorac Cardiovasc Surg. 2019 Aug;158(2):570-578.e3. doi: 10.1016/j.jtcvs.2019.02.123. Epub 2019 Mar 28.
2
Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.特发性肺纤维化和间质性肺疾病患者的肺癌特征——机构和人群数据分析。
Respir Res. 2018 Oct 3;19(1):195. doi: 10.1186/s12931-018-0899-4.
3
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Int J Mol Sci. 2021 Nov 10;22(22):12179. doi: 10.3390/ijms222212179.
特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
4
Japanese guideline for the treatment of idiopathic pulmonary fibrosis.日本特发性肺纤维化治疗指南。
Respir Investig. 2018 Jul;56(4):268-291. doi: 10.1016/j.resinv.2018.03.003. Epub 2018 Jul 3.
5
Which T descriptor is more predictive of recurrence after sublobar resection: whole tumour size versus solid component size?哪种 T 描述符对亚肺叶切除术后复发更具预测性:肿瘤整体大小还是实性成分大小?
Eur J Cardiothorac Surg. 2018 Dec 1;54(6):1028-1036. doi: 10.1093/ejcts/ezy225.
6
Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease.间质性肺疾病患者非小细胞肺癌完全切除术后的长期生存情况。
Interact Cardiovasc Thorac Surg. 2018 Apr 1;26(4):638-643. doi: 10.1093/icvts/ivx400.
7
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.特发性肺纤维化的诊断标准:弗利彻协会白皮书。
Lancet Respir Med. 2018 Feb;6(2):138-153. doi: 10.1016/S2213-2600(17)30433-2. Epub 2017 Nov 15.
8
Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.肺叶切除术与亚肺叶切除术治疗特发性肺纤维化合并临床Ⅰ期非小细胞肺癌的结果。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):1089-1096.e1. doi: 10.1016/j.jtcvs.2017.03.116. Epub 2017 Apr 4.
9
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.围手术期使用吡非尼酮治疗对合并特发性肺纤维化的肺癌患者的影响。
Ann Thorac Surg. 2016 Dec;102(6):1905-1910. doi: 10.1016/j.athoracsur.2016.05.094. Epub 2016 Aug 18.
10
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).一项评估围手术期使用吡非尼酮预防接受肺切除术的肺癌患者特发性肺纤维化急性加重的疗效和安全性的II期试验:日本西部肿瘤学组6711L(PEOPLE研究)。
Respir Res. 2016 Jul 22;17(1):90. doi: 10.1186/s12931-016-0398-4.